| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |